Discover 3,617 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,617
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for
Bipolar I Disorder
Location: Orange CA, Garden Grove CA, Bellflower CA, Torrance CA,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07494305
Phase 2, Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Orange CA, Garden Grove CA, Chino CA, Montclair CA,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07226661
Phase 2, Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia (APL),
Location: Orange CA, Irvine CA, Duarte CA, Los Angeles CA,
Sponsor: Quetzal Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07504458
Phase 3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Orange CA, Fountain Valley CA, Irvine CA, La Jolla CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Orange CA, Los Angeles CA, Phoenix AZ, Eugene OR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Orange CA, Fullerton CA, Phoenix AZ, Scottsdale AZ,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Orange CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Orange CA, Los Angeles CA, San Francisco CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Location: Orange CA, Duarte CA, Scottsdale AZ, San Antonio TX,
Sponsor: Plexium, Inc.
Sex: All
Age: 18+
Code: NCT07284186
Phase 1, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Orange CA, Downey CA, Baldwin Park CA, Harbor City CA,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Orange CA, San Francisco CA, Vancouver, Mansfield TX,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase 2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Orange CA, Irvine CA, La Jolla CA, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase 3, Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for
Non-Small Cell Lung Cancer
Location: Orange CA, Irvine CA, Reno NV, Edwards CO, Portland OR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07100080
Phase 2, Phase 3, Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Orange CA, Los Angeles CA, West Valley City UT,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase 1, Phase 2, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Orange CA, Fountain Valley CA, Irvine CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
for
Schizophrenia
Location: Orange CA, San Jose CA, El Paso TX, Omaha NE,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07101094
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Orange CA, Los Angeles CA, San Francisco CA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue